Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery
NCT07614438Phase 2Not yet recruiting
- Sponsor
- Fondation Hôpital Saint-Joseph
- Start
- Aug 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vasopressin in chronic thromboembolic pulmonary hypertension (CTEPH) (2 arms), sponsored by Fondation Hôpital Saint-Joseph. Primary endpoint: Mean Pulmonary Artery Pressure. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
vasopressin
03
Conditions
chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on NCT07614438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07614438.